TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
|
5,868
|
0 |
Financial expenses |
3,784
|
8,686
|
3,437 |
Earnings before taxes |
-18,442
|
-63,657
|
-53,545 |
EBITDA |
-14,665
|
-54,974
|
-50,109 |
Total assets |
72,948
|
120,271
|
118,309 |
Current assets |
72,921
|
40,758
|
27,803 |
Current liabilities |
31,814
|
43,848
|
47,874 |
Equity capital |
41,132
|
76,079
|
69,413 |
- share capital |
1,775
|
1,306
|
863 |
Employees (average) |
7
|
8
|
6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
56.4%
|
63.3%
|
58.7% |
Turnover per employee |
0
|
734
|
0 |
Profit as a percentage of turnover | -1084.8% | ||
Return on assets (ROA) |
-20.1%
|
-45.7%
|
-42.4% |
Current ratio |
229.2%
|
93.0%
|
58.1% |
Return on equity (ROE) |
-44.8%
|
-83.7%
|
-77.1% |
Change turnover |
-5,868
|
5,868
|
0 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
2
|
0 |
Chg. No. of employees % |
-13%
|
33%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.